CASTLE BIOSCIENCES INC's ticker is CSTL and the CUSIP is 14843C105. A total of 1 filers reported holding CASTLE BIOSCIENCES INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $76,000 | +94.9% | 4,459 | +54.8% | 0.00% | – |
| Q2 2023 | $39,000 | -17.0% | 2,880 | +40.5% | 0.00% | – |
| Q1 2023 | $47,000 | -52.5% | 2,050 | -51.5% | 0.00% | – |
| Q4 2022 | $99,000 | +22.2% | 4,227 | +36.0% | 0.00% | – |
| Q3 2022 | $81,000 | -28.9% | 3,107 | -40.2% | 0.00% | – |
| Q2 2022 | $114,000 | +52.0% | 5,192 | +212.4% | 0.00% | – |
| Q1 2022 | $75,000 | -65.0% | 1,662 | -66.8% | 0.00% | – |
| Q4 2021 | $214,000 | +5.9% | 5,004 | +65.3% | 0.00% | – |
| Q3 2021 | $202,000 | +55.4% | 3,027 | +70.5% | 0.00% | – |
| Q2 2021 | $130,000 | +22.6% | 1,775 | +15.3% | 0.00% | – |
| Q1 2021 | $106,000 | -40.8% | 1,540 | -42.5% | 0.00% | – |
| Q4 2020 | $179,000 | -22.2% | 2,676 | -40.2% | 0.00% | – |
| Q3 2020 | $230,000 | +1252.9% | 4,475 | +879.2% | 0.00% | – |
| Q2 2020 | $17,000 | +183.3% | 457 | +136.8% | 0.00% | – |
| Q1 2020 | $6,000 | -33.3% | 193 | -29.6% | 0.00% | – |
| Q4 2019 | $9,000 | – | 274 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG Innovation Capital Partners III GP Ltd | 33,626 | $567,943 | 77.21% |
| Millrace Asset Group, Inc. | 77,315 | $1,306 | 1.61% |
| Granahan Investment Management | 2,487,673 | $42,016,797 | 1.50% |
| Parkman Healthcare Partners LLC | 224,592 | $3,793,359 | 0.70% |
| PERKINS CAPITAL MANAGEMENT INC | 29,160 | $493 | 0.49% |
| Capital Impact Advisors, LLC | 16,554 | $279,597 | 0.47% |
| Soleus Capital Management, L.P. | 283,500 | $4,788,315 | 0.44% |
| Portolan Capital Management | 253,028 | $4,273,643 | 0.40% |
| Numerai GP LLC | 68,163 | $1,151,273 | 0.38% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 946,620 | $15,988,412 | 0.35% |